Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
From discovery through emergency use to the present: Safety evaluation of the COVID-19 mRNA-1273 (Moderna) vaccine.
Journal: Human vaccines & immunotherapeutics
Published: April 22, 2026
Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines.
Journal: Vaccine
Published: February 05, 2026
Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial.
Journal: Open forum infectious diseases
Published: December 11, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Journal: Science (New York, N.Y.)
Published: May 15, 2025
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.
Journal: Open forum infectious diseases
Published: October 02, 2023
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
Journal: Vaccine
Published: May 24, 2022
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database.
Journal: Expert opinion on drug safety
Published: March 02, 2022
Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 22, 2021
A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.
Journal: The Pediatric infectious disease journal
Published: October 25, 2021
Integrative Analysis of Randomized Clinical Trial and Observational Study Data to Inform Post-marketing Safety Decision-Making.
Journal: Therapeutic innovation & regulatory science
Published: February 06, 2021
Evaluation of Neural Tube Defects (NTDs) After Exposure to Raltegravir During Pregnancy.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 26, 2019
Last Updated: 09/26/2026